• Savara (SVRA) Stock May Trade At A Premium On Pipeline Expectations simplywall.st Wed, 08 Jul 2026 12:11:43 GMT
• HOT Like You: Infinix and Savara Launch the HOT 70 Series to Celebrate Kenya's Slash Youth Generation the-star.co.ke Mon, 06 Jul 2026 12:01:00 GMT
• Enterprise value to EBIT forward of Savara, Inc. – NASDAQ:SVRA TradingView Sun, 05 Jul 2026 00:03:03 GMT
• enterprise value to ebitda forward of savara, inc. – nasdaq:svra TradingView Sat, 04 Jul 2026 05:10:07 GMT
• Savara Inc focuses on respiratory drug development as investors watch clinical progress AD HOC NEWS Fri, 03 Jul 2026 17:46:23 GMT
• enterprise value to revenue forward of savara, inc. – nasdaq:svra TradingView Tue, 30 Jun 2026 13:36:53 GMT
• Does FDA Review of MOLBREEVI and Insider Sales Shift the Bull Case For Savara (SVRA)? simplywall.st Mon, 29 Jun 2026 23:53:34 GMT
• savara inc. (svra) class action lawsuit: levi & korsinsky reminds investors of november 7, 2025 deadline The National Law Review Mon, 29 Jun 2026 17:00:03 GMT
• svra q1 2026 earnings: eps misses estimates as clinical development advances - growth acceleration report dars.gov.et Mon, 29 Jun 2026 01:42:43 GMT
• SVRA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno The National Law Review Sun, 28 Jun 2026 17:09:40 GMT
• levi & korsinsky notifies savara inc. (svra) investors - lead plaintiff deadline on november 7, 2025 The National Law Review Sun, 28 Jun 2026 16:47:42 GMT
• Levi & Korsinsky Notifies Savara Inc. (SVRA) Shareholders of Class Action Lawsuit and November 7, 2025 Deadline The National Law Review Sun, 28 Jun 2026 16:11:00 GMT
• Is Savara (SVRA) Expensive As Its Rally Puts A Premium On Book Value? simplywall.st Sun, 28 Jun 2026 15:53:59 GMT
• SVRA Q1 2026 Earnings: Wider‑than‑Expected Loss Highlights Cash Burn Focus - Guidance Upgrade Report dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• what savara investors should know about this 580,187-option exercise and fda timeline AOL.com Sun, 28 Jun 2026 05:29:58 GMT
• What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline AOL.com Sat, 27 Jun 2026 07:00:00 GMT
• what does the fda's priority review mean for savara's molbreevi Kavout | AI Fri, 26 Jun 2026 05:24:24 GMT
• savara inc (svra) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Form 4 Savara Inc For: 22 June By Investing.com Investing.com Australia Tue, 23 Jun 2026 01:05:22 GMT
• savara cfo david lowrance sells $2.24m in company stock by investing.com Investing.com UK Tue, 23 Jun 2026 00:30:00 GMT
• savara (svra) cfo exercises 580k options and sells 394k shares in form 4 Stock Titan Tue, 23 Jun 2026 00:29:56 GMT
• form 144 savara inc for: 22 june by investing.com Investing.com India Mon, 22 Jun 2026 19:25:17 GMT
• Savara (SVRA) CFO exercises 580K options and sells 394K shares in Form 4 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• savara cfo david lowrance sells $2.24m in company stock Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Savara Stock - Long-term pipeline story in rare lung disease AD HOC NEWS Sat, 20 Jun 2026 12:16:13 GMT
• does savara’s expanded share pool and cfo shift reframe its capital strategy narrative (svra)? simplywall.st Sat, 20 Jun 2026 07:00:00 GMT
• savara stock - analyst focus and sector backdrop for pulmonary care Ad-hoc-news.de Fri, 19 Jun 2026 17:04:47 GMT
• savara inc (svra) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 07:59:10 GMT
• savara inc (svra) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• savara inc (svra) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• savara inc (svra) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• savara inc (svra) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• savara inc (svra) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 09:20:47 GMT
• Savara Inc (SVRA) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 05:53:48 GMT
• Savara Inc (SVRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 05:51:14 GMT
• savara inc (svra) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 05:50:58 GMT
• savara inc (svra) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 02:27:42 GMT
• savara inc (svra) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 02:25:34 GMT
• savara inc (svra) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 02:19:17 GMT
• savara inc (svra) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 02:17:53 GMT
• H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• what is driving attention toward savara’s rare disease strategy? Kalkine Media Mon, 15 Jun 2026 05:42:00 GMT
• savara: lowrance will remain available in advisory capacity >svra Moomoo Mon, 15 Jun 2026 00:56:20 GMT
• savara (svra) stock valuation after cfo transition and leadership change simplywall.st Sun, 14 Jun 2026 11:25:15 GMT
• what is driving attention toward savara’s rare disease strategy? Kalkine Media Sun, 14 Jun 2026 07:00:00 GMT
• savara upgraded at h.c. wainwright on potential refiling of marketing application MSN Fri, 12 Jun 2026 17:52:29 GMT
• how investors are reacting to savara (svra) doubling share authorization and reshaping its cfo role simplywall.st Thu, 11 Jun 2026 04:55:54 GMT
• SVRA Q1 2026 Earnings: EPS Misses Estimates as Pre‑Revenue Biotech Continues R&D Spend - Profit Margin Analysis dars.gov.et Wed, 10 Jun 2026 07:00:00 GMT
• LifeSci Capital Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10 Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• savara shareholders approve share increases and executive changes at annual meeting Investing.com Nigeria Tue, 09 Jun 2026 00:04:04 GMT
• savara (svra) announces leadership changes in finance department GuruFocus Tue, 09 Jun 2026 00:01:54 GMT
• savara: lowrance will remain available in advisory capacity >svra Moomoo Mon, 08 Jun 2026 20:17:00 GMT
• savara inc. announces step down of dave lowrance as chief administrative officer, effective july 15, 2026 marketscreener.com Mon, 08 Jun 2026 20:05:00 GMT
• Savara Announces Chief Financial and Administrative Officer Transition Business Wire Mon, 08 Jun 2026 07:00:00 GMT
• Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term Returns Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• Savara (SVRA) expands share capacity and appoints Robert Lutz as CFO/COO Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Savara (SVRA) Announces Leadership Changes in Finance Department GuruFocus Mon, 08 Jun 2026 07:00:00 GMT
• savara shareholders approve share increases and executive changes at annual meeting Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• savara cfo dave lowrance to step down, robert lutz to expand role Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• savara cfo dave lowrance steps down; coo robert lutz takes on cfo role amid leadership reshuffle Pluang Mon, 08 Jun 2026 07:00:00 GMT
• savara announced that its chief financial and administrative officer, dave lowrance, will officially step down on july 15, 2026. Bitget Mon, 08 Jun 2026 05:07:38 GMT
• assessing savara (svra) valuation as a high price to book meets strong one year shareholder returns simplywall.st Fri, 05 Jun 2026 04:51:05 GMT
• svra: all proposals, including director elections and plan amendments, were approved TradingView Thu, 04 Jun 2026 20:03:44 GMT
• SVRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Advances Pipeline - Earnings Season Preview dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• oppenheimer maintains savara(svra.us) with buy rating, maintains target price $11 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• savara reports long-term phase 3 data supporting molgramostim durability MyChesCo Mon, 01 Jun 2026 23:00:00 GMT
• savara reports phase 3 biomarker gains for rare lung disease MyChesCo Mon, 01 Jun 2026 19:39:05 GMT
• savara reports phase 3 data showing exercise gains in rare lung disease trial MyChesCo Mon, 01 Jun 2026 00:00:00 GMT
• Savara (SVRA) Shows Modest Strength, Holds Above Key Support at $4.94 - Gamma Flip Level dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• Savara Inc. (SVRA) Q1 2026 Earnings: EPS Miss Reflects Investment Phase as Pipeline Advances - Quarterly Earnings Město Břeclav Sat, 30 May 2026 07:00:00 GMT
• savara combines roguelite progression and soulslike combat in a colorful fantasy world Yahoo Tech Sat, 30 May 2026 07:00:00 GMT
• svra q1 2026 earnings: eps misses estimates as company reports no revenue - earnings revision downgrade newsline.com Fri, 29 May 2026 15:42:15 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Fri, 29 May 2026 07:00:00 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Thu, 28 May 2026 20:51:45 GMT
• savara inc stock (us80633a1025): jefferies conference appearance keeps rare-disease biotech in focus AD HOC NEWS Thu, 28 May 2026 07:00:00 GMT
• svra q1 2026 earnings: eps misses estimates as pre-revenue biotech continues pipeline development - analyst coverage count thelegaladvocate.com Wed, 27 May 2026 20:44:37 GMT
• nitin savara re-appointed ne director, campus activewear ltd Whispers In The Corridors Wed, 27 May 2026 17:52:34 GMT
• Savara: The Rare Disease Funnel Is Becoming A Commercial Asset (NASDAQ:SVRA) Seeking Alpha Wed, 27 May 2026 07:00:00 GMT
• rare lung disease biotech savara heads to jefferies investor conference Stock Titan Wed, 27 May 2026 07:00:00 GMT
• savara announces participation in the 2026 jefferies global healthcare conference Yahoo Finance Wed, 27 May 2026 07:00:00 GMT
• tribals fight to protect lands from encroachment in andhra's srikakulam The New Indian Express Tue, 26 May 2026 07:00:00 GMT
• nitin savara re-appointed ne director, campus activewear ltd Whispers In The Corridors Tue, 26 May 2026 05:15:04 GMT
• SVRA Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues Pipeline Progress - Tangible Book Value dars.gov.et Mon, 25 May 2026 07:00:00 GMT
• new apap phase 3 data and wider losses might change the case for investing in savara (svra) simplywall.st Mon, 25 May 2026 07:00:00 GMT
• a look at savara (svra) valuation after positive phase 3 impala 2 data and molbreevi launch preparations simplywall.st Sat, 23 May 2026 14:52:10 GMT
• lifesci capital maintains savara(svra.us) with buy rating, maintains target price $10 Moomoo Sat, 23 May 2026 14:31:00 GMT
• wells fargo maintains savara(svra.us) with buy rating, maintains target price $9 Moomoo Fri, 22 May 2026 07:00:00 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Fri, 22 May 2026 07:00:00 GMT
• Savara, the colorful action roguelite launches Today on PlayStation 5 and Xbox Series X|S Games Press Thu, 21 May 2026 07:00:00 GMT
• Savara Has Finally Arrived on PlayStation 5 and Xbox Series X/S Today COGconnected Thu, 21 May 2026 07:00:00 GMT
• Action Roguelite Savara Launches On PlayStation 5 And Xbox Series X|S The Otaku's Study Thu, 21 May 2026 07:00:00 GMT
• savara inc. (svra) q1 2026 earnings: wider-than-expected loss highlights development-stage costs - consensus forecast report Město Břeclav Thu, 21 May 2026 07:00:00 GMT
• savara inc stock (us80633a1025): fresh impala?2 data at ats 2026 keeps rare?disease bet in focus AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• lifesci capital maintains savara(svra.us) with buy rating, raises target price to $10 Moomoo Thu, 21 May 2026 07:00:00 GMT
• savara presented new biomarker data from the impala-2 phase 3 clinical trial of molgramostim inhalation solution (molgramostim) in... BioSpace Thu, 21 May 2026 02:13:35 GMT
• savara (svra) reports new clinical findings at ats 2026 conferen GuruFocus Wed, 20 May 2026 13:10:29 GMT
• savara , the colorful action roguelite launches today on playstation 5 and xbox series x|s COSMOCOVER Wed, 20 May 2026 09:14:21 GMT
• Savara Is On Xbox And PlayStation – And It Wants You To Earn Every Victory TheXboxHub Wed, 20 May 2026 07:00:00 GMT
• Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in... BioSpace Wed, 20 May 2026 07:00:00 GMT
• rare lung disease trial: savara drug cuts biomarkers tied to severity Stock Titan Wed, 20 May 2026 07:00:00 GMT
• savara presents biomarker data from molgramostim trial at ats Investing.com Wed, 20 May 2026 07:00:00 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Wed, 20 May 2026 07:00:00 GMT
• savara presented long-term efficacy and safety data from the ongoing impala-2 phase 3 clinical trial open-label (ol) extension of ... BioSpace Wed, 20 May 2026 04:41:01 GMT
• savara presents 48-week data on molgramostim for rare lung disease by investing.com Investing.com South Africa Wed, 20 May 2026 01:37:39 GMT
• svra: molbreevi nears approval for apap, backed by strong data and robust commercial preparation TradingView Tue, 19 May 2026 15:05:36 GMT
• savara presented long-term efficacy and safety data from the ongoing impala-2 phase 3 clinical trial open-label (ol) extension of ... Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• savara reports exercise improvements in apap drug trial by investing.com Investing.com Australia Tue, 19 May 2026 07:00:00 GMT
• savara inc stock (us80633a1025): higher losses, trial progress and elevated short interest AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• savara presents 48-week data on molgramostim for rare lung disease Investing.com Tue, 19 May 2026 07:00:00 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Tue, 19 May 2026 07:00:00 GMT
• savara announces new exercise capacity data from the impala-2 phase 3 clinical trial of molgramostim inhalation solution (molgramo... BioSpace Tue, 19 May 2026 01:58:20 GMT
• savara announces new exercise capacity data from the impala-2 phase 3 clinical trial of molgramostim inhalation solution (molgramo... BioSpace Mon, 18 May 2026 07:00:00 GMT
• savara reports exercise improvements in apap drug trial by investing.com Investing.com Canada Mon, 18 May 2026 07:00:00 GMT
• is savara’s rising quarterly loss reshaping the risk‑reward profile for investors in svra? simplywall.st Mon, 18 May 2026 01:45:23 GMT
• savara inc stock (us80633a1025): respiratory disease specialist after latest clinical and funding up AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• is savara’s rising quarterly loss reshaping the risk‑reward profile for investors in svra? Sahm Sun, 17 May 2026 07:00:00 GMT
• a look at savara (svra) valuation as molbreevi advances and q1 2026 results highlight cash and funding plan simplywall.st Sat, 16 May 2026 06:54:05 GMT
• svra stock price, quote & chart | savara inc (nasdaq:svra) ChartMill Fri, 15 May 2026 07:00:00 GMT
• savara stock (us80633a1025): rare disease biotech gains 3.74% on trading momentum AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• guggenheim reaffirms their buy rating on savara (svra) The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• a quick look at today's ratings for savara(svra.us), with a forecast between $9 to $16 Moomoo Wed, 13 May 2026 13:00:01 GMT
• Savara Reports First Quarter Financial Results and Provides Business Update BioSpace Wed, 13 May 2026 07:00:00 GMT
• savara (svra) prepares for commercial launch with strong financi GuruFocus Tue, 12 May 2026 23:26:15 GMT
• bien, savara, coster lead kenya's line up at africa forward summit's le concert standardmedia.co.ke Tue, 12 May 2026 10:04:50 GMT
Savara Inc(NASDAQ:SVRA) 
Savara Inc. operates as an orphan lung disease company. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Aus...
Website: http://www.savarapharma.com
Founded: 1995
Full Time Employees: 36
Founder: Rob Neville, Taneli Jouhikainen
CEO: Matthew Pauls
Sector: Healthcare
Industry: Biotechnology